Analytical Data
-
基因名
VACWR087
- Application
-
别名
VACWR087；Entry-fusion complex Protein OPG094
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P07611
-
表达区间
2-319aa
-
氨基酸序列
GGGVSVELPKRDPPPGVPTDEMLLNVDKMHDVIAPAKLLEYVHIGPLAKDKEDKVKKRYPEFRLVNTGPGGLSALLRQSYNGTAPNCCRTFNRTHYWKKDGKISDKYEEGAVLESCWPDVHDTGKCDVDLFDWCQGDTFDRNICHQWIGSAFNRSNRTVEGQQSLINLYNKMQTLCSKDASVPICESFLHHLRAHNTEDSKEMIDYILRQQSADFKQKYMRCSYPTRDKLEESLKYAEPRECWDPECSNANVNFLLTRNYNNLGLCNIVRCNTSVNNLQMDKTSSLRLSCGLSNSDRFSTVPVNRAKVVQHNIKHSFD
-
分子量
37.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VACWR087 is a recombinant protein derived from the Vaccinia virus, which is a member of the Poxviridae family. The study of VACWR087 is significant due to its potential role in viral pathogenesis and immune evasion mechanisms. Vaccinia virus, historically known for its use in the smallpox vaccine, has garnered attention in recent years for its applications in oncolytic virotherapy and as a vaccine platform. Research on VACWR087 focuses on its interactions with host cellular pathways, which may provide insight into how the virus modulates immune responses. Understanding the structure and function of VACWR087 can reveal critical information about its immunogenic properties and help identify potential targets for therapeutic intervention. Moreover, the insights gained from studying this protein can contribute to the development of novel vaccines and antiviral strategies, highlighting its importance in both basic virology research and applied biomedical fields. Continued exploration of VACWR087 and similar viral proteins emphasizes the intricate relationship between viruses and host systems, paving the way for advancements in vaccine technology and therapeutic approaches against viral infections.
